MediPharm Labs (STU:MLZ) FCF Margin % : 14.84% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. MediPharm Labs's Free Cash Flow for the three months ended in Dec. 2023 was €0.93 Mil. MediPharm Labs's Revenue for the three months ended in Dec. 2023 was €6.24 Mil. Therefore, MediPharm Labs's FCF Margin % for the quarter that ended in Dec. 2023 was 14.84%.

As of today, MediPharm Labs's current FCF Yield % is -39.76%.

The historical rank and industry rank for MediPharm Labs's FCF Margin % or its related term are showing as below:

STU:MLZ' s FCF Margin % Range Over the Past 10 Years
Min: -125.72 Med: -64.47 Max: -38.75
Current: -38.94

During the past 7 years, the highest FCF Margin % of MediPharm Labs was -38.75%. The lowest was -125.72%. And the median was -64.47%.

STU:MLZ's FCF Margin % is ranked worse than
83.45% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.12 vs STU:MLZ: -38.94

MediPharm Labs FCF Margin % Historical Data

The historical data trend for MediPharm Labs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs FCF Margin % Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-44.58

-125.72

-64.47

-76.56

-38.75

MediPharm Labs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-8.51	-52.66	-79.28	-41.05	14.84

Competitive Comparison of MediPharm Labs's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediPharm Labs's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's FCF Margin % falls into.

MediPharm Labs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

MediPharm Labs's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.756	/	22.598
	=	-38.75 %

MediPharm Labs's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0.926	/	6.241
	=	14.84 %

MediPharm Labs FCF Margin % Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs (STU:MLZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines